p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Gynecologic Oncology

• Publication date

  2003-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0090-8258(02)00149-XPMID 12648581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Steroid sulfatase expression in ovarian clear cell adenocarcinoma: immunohistochemical study.

  2001cited by this paper
• p53 mutation is infrequent in clear cell carcinoma of the ovary.

  2001cited by this paper
• Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

  2001cited by this paper
• The Prognostic Significance of Expression of CA125 and Proliferation Markers and Architectural Type in Ovarian Clear Cell Adenocarcinoma

  2000cited by this paper
• Detection of mutation of the p53 gene with high sensitivity by fluorescence-based PCR-SSCP analysis using low-pH buffer and an automated DNA sequencer in a large number of DNA samples.

  2000cited by this paper
• Ovarian endometriosis associated with ovarian carcinoma: a clinicopathological and immunohistochemical study.

  2000cited by this paper
• Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation.

  1999cited by this paper
• Detection and Clinical Correlations of ras Gene Mutations in Human Ovarian Tumors

  1999cited by this paper
• K‐ras mutations in nonmucinous ovarian epithelial tumors

  1998cited by this paper
• Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.

  1998cited by this paper
• Molecular abnormalities in lung cancer.

  1998cited by this paper
• p53 overexpression is Not an independent prognostic factor for patients with primary ovarian epithelial cancer

  1997cited by this paper
• A series of ovarian clear cell and endometrioid carcinoma and their association with endometriosis.

  1997cited by this paper
• SSCP analysis of long DNA fragments in low pH gel

  1997cited by this paper
• Histologic transformation of benign endometriosis to early epithelial ovarian cancer.

  1996cited by this paper
• The Ras signal transduction pathway

  1994cited by this paper
• K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

  1994cited by this paper
• Mutation of the Ki-ras protooncogene in human endometrial hyperplasia and carcinoma.

  1993cited by this paper
• Singapore Med J

  1993cited by this paper
• p53 gene mutations and protein accumulation in human ovarian cancer.

  1993cited by this paper
• p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.

  1993cited by this paper
• K‐ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung

  1993cited by this paper
• Current concepts in epithelial ovarian tumors: does benign to malignant transformation occur?

  1992cited by this paper
• F-SSCP: fluorescence-based polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) analysis.

  1992cited by this paper
• THE P53 TUMOR SUPPRESSOR GENE

  1991cited by this paper
• Allele-specific polymerase chain reaction: a method for amplification and sequence determination of a single component among a mixture of sequence variants.

  1991cited by this paper
• The p53 tumour suppressor gene

  1991cited by this paper
• ras oncogenes in human cancer: a review.

  1989cited by this paper
• Genetic alterations during colorectal-tumor development.

  1988cited by this paper
• Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes.

  1988cited by this paper
• ras genes.

  1987cited by this paper
• Histologic typing of ovarian tumors.

  1987cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• “Mesonephroma” of ovary. Tumor of müllerian nature related to the endometrioid carcinoma

  1967cited by this paper
• Evaluation of survival data and two new rank order statistics arising in its consideration.

  1966cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Molecular Pathology of Ovarian Endometrioid Carcinoma: A Review

  2025cites this paper
• Molecular subtype of ovarian clear cell carcinoma: an analysis of 80 Chinese patients using the TCGA molecular classification of endometrial cancer

  2025cites this paper
• Liquid Biopsy-Based Smart Sensors for Ovarian Cancer Detection.

  2025cites this paper
• Endometriosis-Associated Ovarian Cancer: From Molecular Pathologies to Clinical Relevance

  2024cites this paper
• The status of KRAS mutations in primary ovarian clear cell carcinoma: An analysis of 17 Taiwanese patients.

  2023cites this paper
• Molecular characteristics and clinical behaviour of epithelial ovarian cancers.

  2023cites this paper
• Practical Approach to the Evaluation of Malignant Peritoneal Fluids in the Setting of Gynecologic Neoplasms

  2022cites this paper
• Clinicopathologic Features and the Loss of ARID1A Expression in Ovarian Seromucinous Borderline Tumors and Seromucinous Carcinomas

  2022cites this paper
• KRAS Mutation in Endometriosis-Associated Ovarian Borderline and Malignant Epithelial Tumors

  2022cites this paper
• Co-existing TP53 and ARID1A mutations promote aggressive endometrial tumorigenesis

  2021cites this paper
• Clinicopathological profile of primary ovarian carcinomas

  2021cites this paper
• Intratumoral budding is associated with poor clinical outcome in early‐stage clear cell carcinoma of ovary *

  2021cites this paper
• Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome

  2020cites this paper
• CTNNB1 Mutations and Aberrant β-Catenin Expression in Ovarian Endometrioid Carcinoma

  2020cites this paper
• Ovary and Peritoneal Washings

  2019cites this paper
• Genomic and Molecular Abnormalities in Gynecologic Clear Cell Carcinoma

  2019cites this paper
• Gynaecological Cancer Diagnostics: 99mTc-Cisplatin Complex as a Future Approach for Early, Prompt and Efficient Diagnosis of Gynaecological Cancer.

  2019cites this paper
• Pathology of Endometrioid and Clear Cell Carcinoma of the Ovary.

  2019cites this paper
• Serous Neoplasms of the Ovary

  2019cites this paper
• Polymorphisms and endometriosis: a systematic review and meta-analyses.

  2019cites this paper
• Clear cell carcinomas of the ovary and kidney: clarity through genomics

  2018cites this paper
• Origins based clinical and molecular complexities of epithelial ovarian cancer.

  2018cites this paper
• KRAS mutation testing in borderline ovarian tumors and low-grade ovarian carcinomas with a rapid, fully integrated molecular diagnostic system

  2017cites this paper
• Endometrioid Carcinoma of the Ovary

  2017cites this paper
• Molecular Profiling of Clear Cell Ovarian Cancers

  2016cites this paper
• Hedgehog Signaling Pathway as Genetic and Epigenetic Target in Ovarian Tumors.

  2016cites this paper
• Molecular status of PI3KCA, KRAS and BRAF in ovarian clear cell carcinoma: an analysis of 63 patients

  2016cites this paper
• Biomarkers in Endometrial Cancer

  2015cites this paper
• Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery.

  2015cites this paper
• BRAF mutational analysis in ovarian tumors: recent perspectives

  2015cites this paper
• L'inhibition de l'activité transcriptionnelle de PRDM6 diminue la migration et l'invasion de cellules de cancer ovarien épithélial

  2014cites this paper
• Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer.

  2013cites this paper
• Ovarian cancer as a genetic disease.

  2013influential citation
• Analyse globale des altérations abberantes de la méthylation de l'ADN dans le cancer de l'ovaire

  2013cites this paper
• HNF-1&bgr; in Ovarian Carcinomas With Serous and Clear Cell Change

  2013cites this paper
• Genetics of Endometrial Carcinoma

  2013cites this paper
• In search of new prognostic molecular markers in ovarian cancer

  2012cites this paper
• Clear cell carcinoma of the ovary: Is there a role of histology-specific treatment?

  2012cites this paper
• Sodium arsenite ± hyperthermia sensitizes p53-expressing human ovarian cancer cells to cisplatin by modulating platinum-DNA damage responses.

  2012cites this paper
• Molecular bases of endometrial cancer: new roles for new actors in the diagnosis and the therapy of the disease.

  2012cites this paper
• KRAS mutations in ovarian low-grade endometrioid adenocarcinoma: association with concurrent endometriosis.

  2012cites this paper
• Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress

  2012cites this paper
• Clear Cell Carcinoma of the Ovary

  2011cites this paper
• Mitigating cisplatin resistance in ovarian cancer.

  2011cites this paper
• Mouse Models of Menopause and Ovarian Cancer Risks

  2011cites this paper
• Ovarian Clear Cell Carcinoma

  2011cites this paper
• Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development

  2011cites this paper
• Wild‐type p53 enhances annexin IV gene expression in ovarian clear cell adenocarcinoma

  2011cites this paper
• Two Designated Pathways of Ovarian Cancer and the Crucial Implications to the Treatment

  2011cites this paper
• The Effects of the Female Reproductive Hormones on Ovarian Cancer Initiation and Progression in a Transgenic Mouse Model of the Disease

  2011cites this paper
• Genetic profiles distinguish different types of hereditary ovarian cancer.

  2010cites this paper
• Endometrial carcinomas with ambiguous features.

  2010cites this paper
• Genetics of Endometrial Cancers

  2010cites this paper
• Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases

  2010cites this paper
• Ovarian cancer: pathology, biology, and disease models.

  2009cites this paper
• Epithelial ovarian cancer: Focus on genetics and animal models

  2009cites this paper
• Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary: Distinctive Tumors That Differ in Their Pathogenesis and Behavior: A Clinicopathologic Analysis of 122 Cases

  2009cites this paper
• Pathogenetic Pathways in Ovarian Endometrioid Adenocarcinoma: A Molecular Study of 29 Cases

  2009cites this paper
• Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management

  2009cites this paper
• Two Designated Pathways of Ovarian Cancer and the Crucial Implications to the Treatment (Dua jalur patogenesis kanker ovarium dan implikasi terhadap penatalaksanaannya)

  2009cites this paper
• Prognostic value of hormonal receptors, p53, ki67 and HER2/neu expression in epithelial ovarian carcinoma

  2008cites this paper
• Pathogenesis of Ovarian Cancer: Lessons From Morphology and Molecular Biology and Their Clinical Implications

  2008cites this paper
• Histologic and immunohistochemical decision-making in endometrial adenocarcinoma

  2008cites this paper
• Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers A Gynecologic Oncology Group study.

  2008cites this paper
• Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis.

  2008cites this paper
• Emi1 protein accumulation implicates misregulation of the anaphase promoting complex/cyclosome pathway in ovarian clear cell carcinoma

  2008cites this paper
• GENOMIC AND TRANSCRIPTOME PROFILING OF EPITHELIAL OVARIAN CANCER

  2008cites this paper
• Clear cell adenocarcinoma arising from a giant cystic adenomyosis: a case report with immunohistochemical analysis of laminin-5 gamma2 chain and p53 overexpression.

  2008cites this paper
• Ovarian Serous Carcinogenesis—A Proposed Model

  2007cites this paper
• Prognostic significance of apoptotic activity and its relationship with morphological characteristics in clear cell ovarian adenocarcinoma.

  2007cites this paper
• Bias versus causality: interpreting recent evidence of association between endometriosis and ovarian cancer.

  2007cites this paper
• Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis.

  2006influential citation
• Immunohistochemical localization of inhibin and activin subunits, activin receptors, and Smads in ovarian clear cell adenocarcinoma.

  2006cites this paper
• Interleukin‐13 receptor α2 chain

  2006cites this paper
• Ovarian clear cell adenocarcinoma: a continuing enigma

  2006cites this paper
• Tumorigenesis of K-ras mutation in human endometrial carcinoma via upregulation of estrogen receptor.

  2006cites this paper
• P53 mutations in tissue from Danish ovarian cancer patients: from the Danish "MALOVA" ovarian cancer study.

  2006cites this paper
• Activation of mammalian target of rapamycin in postmenopausal ovarian endometriosis

  2006cites this paper
• High frequency of β‐catenin mutations in borderline endometrioid tumours of the ovary

  2006cites this paper
• Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.

  2006cites this paper
• Cyclooxygenase-2 expression is higher in ovarian cancer tissue adjacent to endometriosis than in ovarian cancer without comorbid endometriosis.

  2006cites this paper
• p53, epidermal growth factor, and platelet-derived growth factor in uterine leiomyosarcoma and leiomyomas

  2005cites this paper
• Molecular pathology of ovarian cancer.

  2005cites this paper
• Involvement of the ras genes in female genital tract cancer.

  2005cites this paper
• Clear‐cell cancer of the ovary—is it chemosensitive?

  2005cites this paper
• Clinical and biological characteristics of clear cell carcinomas of the ovary in FIGO stages I-II.

  2005cites this paper
• Origins and molecular pathology of ovarian cancer

  2005cites this paper
• Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer

  2005cites this paper
• Disappearance of Steroid Hormone Dependency During Malignant Transformation of Ovarian Clear Cell Cancer

  2005cites this paper
• Paradoxes of Non-Trivial Gene Networks: How Cancer-Causing Mutations Can Appear to Be Cancer-Protective

  2004cites this paper
• K-ras mutation may promote carcinogenesis of endometriosis leading to ovarian clear cell carcinoma

  2004influential citation
• Genetics of endometriosis: heritability and candidate genes.

  2004cites this paper
• Critical evaluation of p53 as a prognostic marker in ovarian cancer

  2004cites this paper
• Chapter 16 – Molecular Genetics of Endometrial Cancers

  2004cites this paper
• Review Ovarian Tumorigenesis A Proposed Model Based on Morphological and Molecular Genetic Analysis

  2004cites this paper
• Gynecologic oncology and pathology Biomarkers, X-rays and antibodies: detection of recurrent ovarian cancer Related review: Newmodalities in detection of recurrent ovarian cancer (pp. 5–9)

  2004cites this paper
• Clear-cell cancer of the ovary—is it chemosensitive?

  2004cites this paper
• Signature of a silent killer: expression profiling in epithelial ovarian cancer

  2004cites this paper
• Malignant transformation of endometriosis and genetic alterations of K‐ras and microsatellite instability

  2004cites this paper
• Relationship between Malignant Transformation of Endometriosis and Genetic Alterations of K-ras and Microsatellite Instability

  2004cites this paper